Topic search: CANCER AND AIDS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Refine your search by entering keywords here:

AIDS and Cancer Journal Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2024 Pg. 278-281	Ketamine for Pain in Hospice Patients - A Transdermal Gel Applied to the Painful Site Author(s): Wood Robert M
Mar/Apr 2023 Pg. 154-159	Extending Practical (In Use) Shelf Life of Oncology Drug Vials Using Spikes Author(s): de Wilde Sofieke, Crul Mirjam, Breukels Oscar
Jan/Feb 2023 Pg. 53	Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 510	Diazoxide 10-mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 513	Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 316	Calculations Author(s): Stockton Shelly J
Jan/Feb 2022 Pg. 6-8	Compounded Melatonin Cream for the Prevention and Treatment of Radiation Dermatitis: A Case Report Author(s): Garcia-Segura Laura Corral, Garcia-Segura Javier Corral, Delgado Carlos Dorado, Maldonaldo Nuria Romero, Salgado Elena Cardero, Llorens Lucía Pérez
Sep/Oct 2021 Pg. 420	Sorafenib 20-mg/mL in Oil Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 270-274	Growing a Compounding Practice: Successful Marketing to Underserved Populations Author(s): McKettrick Greg, Yoch Doug
Jul/Aug 2021 Pg. 326	Moh's Paste, Modified Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 234	Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 235	Temozolomide 10 mg/mL in Oral Mix SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 246-257	Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Author(s): Hui Ada, Yin Jian, Liu Wei, Zheng Kai
Mar/Apr 2021 Pg. 94-98	The Stanley Prostate-cancer Treatment Protocol for Erectile Dysfunction After Prostatectomy and/or Radiotherapy: A Case Report Author(s): McKettrick Greg, Yoch Doug
Jan/Feb 2021 Pg. 31-38	Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 43	Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Jan/Feb 2020 Pg. 52	Calculations Author(s): Stockton Shelly J
Jan/Feb 2020 Pg. 83-85	Compatibility of Melphalan in Iodinated Contrast Media Author(s): Shi Zhanquan, Abruzzo Todd, Wanasathop Apipa, Li S Kevin
Sep/Oct 2019 Pg. 358-364	Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Author(s): Pope George, Daleo Charles, Batson SL
Sep/Oct 2019 Pg. 411	Sorafenib Capsules for Pediatric Use Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 235	Methotrexate 2-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 54	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 446-454	Treatment of Dermatologic Adverse Events Induced by Oncological Treatments Using Compounded Medications Author(s): Zur Eyal
Nov/Dec 2018 Pg. 496	Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 417-423	Prolonged In-use Stability of Reconstituted Herceptin in Commercial Intravenous Bags Author(s): Nalenz Heiko, Köpf Ellen, Dietel Elke
Jul/Aug 2018 Pg. 314	Calculations Author(s): Stockton Shelly J
Jul/Aug 2018 Pg. 318	Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 345-349	Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags Author(s): Breukels Oscar, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 151	Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 51	Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 58	Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 60-65	Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Author(s): Song Guiyun, Banov Daniel, Bassani August S
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Sep/Oct 2017 Pg. 410	Etoposide 20-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 347-351	Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia Author(s): Robert Julien, Sorrieul Jérémy, Rossignol Elsa, Beaussart Hélène, Kieffer Hélène, Folliard Caroline, Dupoiron Denis, Devys Catherine
Mar/Apr 2017 Pg. 146	Azathioprine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 58-59	Calculations Author(s): Stockton Shelly J
Jan/Feb 2017 Pg. 66-75	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2017 Pg. 76-82	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Author(s): Wu George, Yeung Stanley, Chen Frank
Nov/Dec 2016 Pg. 508	Erlotinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 510	Imatinib 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 511	Lapatinib Ditosylate 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 405	Calculations Author(s): Stockton Shelly J
Jul/Aug 2016 Pg. 327	Tretinoin 10-mg Oral Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 226	Carboplatin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 48	Aprepitant 80-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 81-85	Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
Nov/Dec 2015 Pg. 502	Calculations Author(s): Stockton Shelly J
Jul/Aug 2015 Pg. 328	Cytarabine 50-mg/mL Injection Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 333	Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Author(s): Allen Loyd V
Jul/Aug 2015 Pg. 344-347	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Author(s): Anderson Collin R, Halford Zachery, MacKay Mark
May/Jun 2015 Pg. 261-267	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Author(s): Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin
Jan/Feb 2015 Pg. 62	Cisplatin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 63	Daunorubicin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 73-77	Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Author(s): Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
Nov/Dec 2014 Pg. 497	Leucovorin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 520-525	High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
Sep/Oct 2014 Pg. 358-364	Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy Author(s): Palma Elisabetta, Bufarini Celestino
Jul/Aug 2014 Pg. 328	Denileukin Diftitox 150-mcg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 238	Methotrexate 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 240	Tamoxifen 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 143	Fludarabine Phosphate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 148	Secretin 4 mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 63	Lomustine 100-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 446-450	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Nov/Dec 2013 Pg. 506	Metyrosine 250-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 388-391	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2013 Pg. 417	Fluorouracil 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 420	Mesna 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 421	Methotrexate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 330	Dacarbazine 200-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 234	Mercaptopurine 75-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 262-263	PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial Author(s): Williams LaVonn A
Mar/Apr 2013 Pg. 149	Dexrazoxane 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 151	Paclitaxel 6-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 152	Thiotepa 15-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 72	Octreotide 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 73	Testosterone Cypionate 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 498-499	Calculations Author(s): Stockton Shelly J, Saluja Hardeep Singh
Sep/Oct 2012 Pg. 431-433	Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Sep/Oct 2012 Pg. 434-437	Compounding of Slow-release Niacinamide Capsules: Feasibility and Characterization Author(s): Radojkovic Branko, Milic Jela, Calija Bojan
Jul/Aug 2012 Pg. 339	Ondansetron Hydrochloride 2-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 117-124	Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum Author(s): Zur Eyal
Jan/Feb 2012 Pg. 82-85	Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration Author(s): Zhang Yang, Scarlett Cameron, Hutson Paul
Jan/Feb 2012 Pg. 22-33	Oral Mucositis: Etiology and Clinical and Pharmaceutical Management Author(s): Zur Eyal
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2011 Pg. 506	Thioguanine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 504	Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 515-520	Physiochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags Author(s): Kaiser Jeanette, Kramer Irene
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 428-434	Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Author(s): Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice
Jul/Aug 2011 Pg. 340	Methylprednisolone 4-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 428	Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 210-213	Potential Treatments for Radiation Dermatitis Author(s): Corsini Lindsay
May/Jun 2010 Pg. 245	Cyclophosphamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 248	Sunitinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 100-104	Hormonal Influences in Prostate Cancer: An Update of a Complex Subject Author(s): Biundo Bruce
Mar/Apr 2010 Pg. 118-123	Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Author(s): McElhiney Linda F
Sep/Oct 2009 Pg. 434	Mechlorethamine Hydrochloride 0.02% Topical Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 435	Myristyl Nicotinate 5% Topical Gel Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 153	Aprepitant 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 155	Doxorubicin Hydrochloride 1-mg/mL in Sodium Chloride Solution Intravesical Instillation Author(s): Allen Loyd V Jr
Mar/Apr 2009 Pg. 156	Ionic Hydration Solution for Anti-Cancer Therapy Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 42-49	Compounding for Cancer in Companion Animals Author(s): Mixon William, Northrup Nicole, Vail Jane
Sep/Oct 2008 Pg. 460-462	Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Nov/Dec 2008 Pg. 482-487	Compounding Challenges for Immunocompromised Patients Author(s): McElhiney Linda F
Jul/Aug 2008 Pg. 361	Tretinoin and Dexpanthenol Gel Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 368-371	Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Jan/Feb 2008 Pg. 16-27	Cancer-Related Terminology: Glossaries for Compounding Pharmacists and Their Clients Author(s): Williams LaVonn A
Jan/Feb 2008 Pg. 28-37	Hospice and Compounding Pharmacy: Once Inseperable Author(s): Williams LaVonn A
Jan/Feb 2008 Pg. 62	Calculations: Compounding for Cancer Patients Author(s): Stockton Shelly J
Jul/Aug 2007 Pg. 336	Temozolomide 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 212-218	Levorphanol for Excruciating Pain from Oral Cancer: A Case Report Author(s): McNulty Jack P
Mar/Apr 2007 Pg. 155	Busulfan 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 158	Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 160	Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 10-15	Principles of Pediatric Palliative Care and Pain Control Author(s): Peralta Alexander Jr
Jan/Feb 2007 Pg. 82-85	Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Nov/Dec 2006 Pg. 454	Cyclophosphamide 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 336-342	Dermatological Effects from Years in the Sun: Compounding Opportunities Author(s): Jones Marty
Sep/Oct 2006 Pg. 384	Hydroxyurea 100 mg/mL Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 385	Indinavir 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 396-399	Temozolomide Stability in Extemporaneously Compounded Oral Suspensions Author(s): Trissel Lawrence A, Zhang Yanping, Koontz Susannah E
Jul/Aug 2006 Pg. 305	Rifabutin 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 222	Granisetron 0.05-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 224	Mesna 20-mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 234-236	Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
Jan/Feb 2006 Pg. 59	Chlorambucil 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 62	Efavirenz 20-mg/mL Oral Liquid, Anhydrous Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 64	Mercaptopurine 50-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2006 Pg. 68	Thioguanine 40-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 475	Dolasetron 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 312	Brompton's Mixture Author(s): Allen Loyd V Jr
Jul/Aug 2005 Pg. 320-322	Physical and Chemical Stability of Palonosetron Hydrochloride with Fluorouracil and with Gemcitabine Hydrochloride during Simulated Y-site Administration Author(s): Trissel Lawrence A, Zhang Yanping
May/Jun 2005 Pg. 195-198	Compounding Antiangiogenic Cancer Therapy for Animals Author(s): Davidson Gigi S
May/Jun 2005 Pg. 234	Piroxicam 2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 235-237	Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
May/Jun 2005 Pg. 238-241	Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
Sep/Oct 2004 Pg. 324-327	Book and Literature Reviews Author(s): Reed-Kane Dana, Foy Elizabeth, MacCara Mary E, MacLean Lindsay
Sep/Oct 2004 Pg. 383	Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2004 Pg. 244-249	Book and Literature Reviews Author(s): Reed-Kane Dana, Foy Elizabeth, MacCara Mary E
Jul/Aug 2004 Pg. 296	Diphenhydramine HCl 0.1%, Lidocaine HCl 1%, Misoprostol 0.0024% and Triamcinolone Acetonide 0.12% Oral Rinse Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 218	Glycopyrrolate 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 140	Stomatitis Mouthwash Author(s): Allen Loyd V Jr
Mar/Apr 2004 Pg. 141	Tacrolimus 0.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2003 Pg. 386-388	Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Author(s): Gupta Vishnu D
May/Jun 2003 Pg. 183	ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Author(s): Allen Loyd V Jr
Jul/Aug 2002 Pg. 250-254	The Hormonal Link to Breast Cancer: The Estrogen Matrix Author(s): Zava David T
Mar/Apr 2002 Pg. 140-141	Sterilization of Talc for Use in Pleurodesis Author(s): Fehr Richard, Henke Michelle, Ashworth Lisa D
Jul/Aug 2001 Pg. 268-271	Antineoplastic Agents Author(s): Ashworth Lisa D
Jul/Aug 2001 Pg. 320-322	A New High-Performance Liquid Chromatographic Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes Author(s): Abang Anthony M, Abbas S Ali, Pham Trinh, Lambros Maria Polikandritou
May/Jun 2001 Pg. 209	Mitomycin 0.02% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 51	Promethazine HCl 50-mg/mL in PLO Gel Author(s): Allen Loyd V Jr
Sep/Oct 2000 Pg. 334	Human Immunodeficiency Virus and the Acquired Immune Deficiency Syndrome Author(s): Mathews Elizabeth
Jul/Aug 2000 Pg. 246-249	Hospice and the Role of the Compounding Pharmacist Author(s): Carling Maureen A
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
Jul/Aug 2000 Pg. 253-254	Ketamine for Pain in Hospice Patients Author(s): Wood Robert M
Jul/Aug 2000 Pg. 255-256	Custom-Making Medications for the Hospice Patient Author(s): Horwitz Robert
Jul/Aug 2000 Pg. 257-260	Surviving Cancer - How the Compounding Pharmacist Can Help Author(s): Maddox Suzan
Jul/Aug 2000 Pg. 264-272	Providing Positive Outcomes through Compounding for Animal Cancer Patients Author(s): Davidson Gigi S
Jul/Aug 2000 Pg. 296	Dacarbazine 8-mg/mL, Doxorubicin HCl 0.8-mg/mL and Ondansetron 0.64-mg/mL injection Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 297	Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 298	Doxorubicin HCl 0.4-mg/mL, Ondansetron HCl 0.48-mg/mL and Vincristine Sulfate 14-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 302	Misoprostol 0.0024% Mouth Rinse for Oral Ulcerations Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 305	Ondansetron HCl 8-mg/mL in PLO Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 320-323	Stability of 5-Fluorouracil in an Extemporaneously Compounded Ophthalmic Solution Author(s): Fuhrman L Clifton, Godwin Donald A, Davis R Alan
Sep/Oct 1999 Pg. 380-381	Tamoxifen Citrate - A Potential Therapy for the Treatment of Keloids Author(s): Glasnapp Andrew
Sep/Oct 1999 Pg. 381	Tamoxifen Citrate Cream 0.1% Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 241-244	Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C
Jan/Feb 1999 Pg. 10	Oral Ulceration Mouthwash Author(s): Allen Loyd V Jr
Jan/Feb 1999 Pg. 67-68	Five-Day Stability of Vinorelbine in 5% Dextrose Injection and in 0.9% Sodium Chloride Injection at Room Temperature Author(s): Lieu Cynthia L, Chin Alfred, Gill Mark A
Nov/Dec 1998 Pg. 414-415	Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Author(s): Paoletti James E, Benavides Tomas J
Sep/Oct 1998 Pg. 382-384	Compatibility of Paclitaxel Injection Diluent with Two Reduced-Phthalate Administration Sets for the Acclaim Pump Author(s): Xu Quanyun A, Trissel Lawrence A
Jul/Aug 1998 Pg. 300	Fluorouracil 5% Topical Stick Author(s): Allen Loyd V Jr
May/Jun 1998 Pg. 243-245	Paclitaxel Compatibility with IV Express Filter Unit Author(s): Xu Quanyun A, Trissel Lawrence A, Zhang Yanping
Jan/Feb 1998 Pg. 21-23	Estrogen and Breast Cancer: Is There a Link? Author(s): Gever Marcy Portnoff
Jan/Feb 1998 Pg. 83-88	Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Author(s): Tenjarla Srini N, Ward Earl S, Fox Janet L
Jan/Feb 1998 Pg. 89-91	Stability of Mechlorethamine Hydrochloride 0.01% Ointment in Aquaphor® Base Author(s): Zhang Yanping, Trissel Lawrence A, Johansen Jamie F, Kimball Carol L
Nov/Dec 1997 Pg. 386-388	Compounding Pharmacists Play a Vital Role in AIDS Treatment Author(s): Staton Tracy
Sep/Oct 1997 Pg. 324	Doxorubicin HCl-Vincristine Sulfate Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 326	Granisetron HCl-Dexamethasone Sodium Phosphate Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 328	Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 332	Ondansetron HCl-Dexamethasone Sodium Phosphate Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 333	Ondansetron HCl-Doxorubicin HCl-Dacarbazine Injection Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 334	Ondansetron HCl-Doxorubicin Sulfate-Vincristine Sulfate Injection (2 concentrations) Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 282-283	Stability of Mitomycin Aqueous Solution When Stored in Tuberculin Syringes Author(s): Gupta Vishnu D, Maswoswe J
May/Jun 1997 Pg. 175	Antiemetic Injection for Cancer Chemotherapy Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 12	Rectal and Stomal Administration of Analgesic Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 18-19	Aromatherapy and the Hospice Patient Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 26	ABH Hard Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 27	ABH Soft Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 27	ABH Sugar Troche Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 28	Antiemetic Suppositories of the Gralla Type Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 31	Metoclophen Nausea Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 31	Metoclophen-Modified Nausea Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 34-35	Ondansetron HCl Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 37	Scopolamine Hydrobromide 0.4-mg/0.1-mL Nasal Solution Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 38	Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 1997 Pg. 49-53	Compounding an Extended Stability Admixture of Paclitaxel for Long-Term Infusion Author(s): Trissel Lawrence A, Xu Quanyun, Martinez Juan F